BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36170616)

  • 21. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
    Zhou L; Xu J; Wang S; Yang X; Li C; Zhou J; Zhang P; Xu H; Wang C
    Int J Surg Pathol; 2020 Oct; 28(7):728-734. PubMed ID: 32403965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour].
    Yang X; Miao N; Gan H; Wang L; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature.
    Tu X; Zhuang X; Chen Q; Wang W; Huang C
    Front Oncol; 2023; 13():1101268. PubMed ID: 37007143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.
    Renshaw AA; Granter SR; Fletcher JA; Kozakewich HP; Corless CL; Perez-Atayde AR
    Am J Surg Pathol; 1999 Jul; 23(7):795-802. PubMed ID: 10403302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.
    Farcaş M; Gatalica Z; Trpkov K; Swensen J; Zhou M; Alaghehbandan R; Williamson SR; Magi-Galluzzi C; Gill AJ; Tretiakova M; Lopez JI; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Siadat F; Sangoi A; Gao Y; Ptákova N; Kuthi L; Pivovarcikova K; Rogala J; Agaimy A; Hartmann A; Fraune C; Rychly B; Hurnik P; Durcansky D; Bonert M; Gakis G; Michal M; Hora M; Hes O
    Mod Pathol; 2022 Mar; 35(3):344-351. PubMed ID: 34521993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 33. Papillary renal neoplasm with reverse polarity: A case report.
    Xing C; Tian H; Zhang Y; Zhang L; Kong J
    Front Oncol; 2023; 13():1072213. PubMed ID: 37143937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
    Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
    Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
    Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases.
    Tretiakova MS
    Hum Pathol; 2018 Oct; 80():65-75. PubMed ID: 29885406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
    Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
    Mantilla JG; Antic T; Tretiakova M
    Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
    Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
    Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
    Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.